In solid tumors, usually, it is more common to recognize a tumor-associated antigen (TAA) wherever the expression of markers, such as CEA, ERBB2, EGFR, GD2, mesothelin, MUC1, and PSMA, is increased on cancer cells. This evidence concerns the gene ERBB2 and cancer.